Renoprotective effects of DNAse-I treatment in a rat model of ischemia/reperfusion-induced acute kidney injury

American Journal of Nephrology

Volumn 43, Issue 3, 2016, Pages 195-205

  Peer, Victoria ^a   Abu Hamad, Ramzia ^a   Berman, Sylvia ^a   Efrati, Shai ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute kidney injury; Acute tubular necrosis; Apoptosis; Cell free DNA; DNAse I; Hypoxia; Ischemia reperfusion; Proliferation

Indexed keywords

DEOXYRIBONUCLEASE I; SODIUM CHLORIDE; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG EFFECT; HISTOPATHOLOGY; HYPOXIA; KIDNEY ARTERY; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; UNINEPHRECTOMY; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; KIDNEY CIRCULATION; PRECLINICAL STUDY;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BIOMARKERS; CELL PROLIFERATION; DEOXYRIBONUCLEASE I; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; MALE; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; REPERFUSION INJURY;

EID: 84963543125     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000445546     Document Type: Article

References (36)

1. Skorecki K, Chertow GM, Marsden PA, Taal MW, Yu ASL. Approach to the patient with kidney disease; in Brenner and Rector's The Kidney, 2012, Chapter 24, pp 859-860.
2. Gueler F, Gwinner W, Schwarz A, Haller H. Long-Term effects of acute ischemia and reperfusion injury. Kidney Int 2004; 66: 523-527.
3. Thurman JM. Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 2007; 123: 7-13.
4. Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011; 121: 4210-4221.
5. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365: 417-430.
6. Brezis M, Rosen S, Silva P, Epstein FH. Renal ischemia: a new perspective. Kidney Int 1984; 26: 375-383.
7. Schurek HJ, Jost U, Baumgartl H, Bertram H, Heckmann U. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol 1990; 259(6 pt 2):F910-F915.
8. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
9. Krishan P, Sharma A, Singh M. Effect of angiotensin converting enzyme inhibitors on ischaemia-reperfusion-induced renal injury in rats. Pharmacol Res 1998; 37: 23-29.
10. Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E. An angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Ann Clin Lab Sci 2006; 36: 326-332.
11. Atamaniuk J, Ruzicka K, Stuhlmeier KM, Karimi A, Eigner M, Mueller MM. Cell-free plasma DNA: a marker for apoptosis during hemodialysis. Clin Chem 2006; 52: 523-526.
12. Seredkina N, Rekvig OP. Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis. Am J Pathol 2011; 179: 1120-1128.
13. Fismen S, Mortensen ES, Rekvig OP. Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB. NZW) F1 mice. Immunol Cell Biol 2011; 89: 90-99.
14. Pressler T. Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis. Biologics 2008; 2: 611-617.
15. Seredkina N, Van Der Vlag J, Berden J, Mortensen E, Rekvig OP. Lupus nephritis: enigmas, conflicting models and an emerging concept. Mol Med 2013; 19: 161-169.
16. Stenvinkel P. Inflammation in end-stage renal disease-A fire that burns within. Contrib Nephrol 2005; 149: 185-199.
17. Basnakian AG, Ueda N, Kaushal GP, Mikhailova MV, Shah SV. DNase I-like endonuclease in rat kidney cortex that is activated during ischemia/reperfusion injury. J Am Soc Nephrol 2002; 13: 1000-1007.
18. Basnakian AG, Apostolov EO, Yin X, Napirei M, Mannherz HG, Shah SV. Cisplatin nephrotoxicity is mediated by deoxyribonuclease I. J Am Soc Nephrol 2005; 16: 697-702.
19. Hakkim A, Furnrohr BG, Amann K, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 2010; 107: 9813-9818.
20. Thiyagarajan D, Fismen S, Seredkina N, et al. Silencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin fragments and activation of toll like receptors and the Clec4e. PLoS One 2012; 7:e34080.
21. Zykova SN, Seredkina N, Benjaminsen J, Rekvig OP. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB. NZW)F(1) mice. Arthritis Rheum 2008; 58: 813-825.
22. Zykova SN, Tveita AA, Rekvig OP. Renal DNase1 enzyme activity and protein expression is selectively shut down in murine and human membrano proliferative lupus nephritis. PLoS One 2010; 5:pii:e12096.
23. Silva MT. Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett 2010; 584: 4491-4499.
24. Macanovic M, Sinicropi D, Shak S, Baughman S, Thiru S, Lachmann PJ. The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin Exp Immunol 1996; 106: 243-252.
25. Verthelyi D, Dybdal N, Elias KA, Klinman DM. DNAse treatment does not improve the survival of lupus prone (NZB. NZW)F1 mice. Lupus 1998; 7: 223-230.
26. Davis JC Jr, Manzi S, Yarboro C, et al. Recombinant human Dnase I (rhDNase) in patients with lupus nephritis. Lupus 1999; 8: 68-76.
27. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120:c179-c184.
28. Efrati S, Berman S, Hamad RA, et al. Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury. Nephrol Dial Transplant 2012; 27: 136-145.
29. Nielsen VK, Kemp E, Laursen T. Lactic dehydrogenase in kidney tissue and renal disease. Adaptive change of the synthesis in acute failure. Acta Med Scand 1968; 184: 109-119.
30. Zager RA, Johnson AC, Becker K. Renal cortical lactate dehydrogenase: a useful, accurate, quantitative marker of in vivo tubular injury and acute renal failure. PLoS One 2013; 8: e66776.
31. Weinberg JM, Davis JA, Roeser NF, Venkatachalam MA. Role of intracellular pH during cytoprotection of proximal tubule cells by glycine or acidosis. J Am Soc Nephrol 1994; 5: 1314-1323.
32. Zager RA, Johnson AC, Hanson SY, Wasse H. Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis 2002; 40: 90-103.
33. Zager RA. Uremia induces proximal tubular cytoresistance and heme oxygenase-1 expression in the absence of acute kidney injury. Am J Physiol Renal Physiol 2009; 296:F362-F368.
34. Paragas N, Qiu A, Hollmen M, Nickolas TL, Devarajan P, Barasch J. NGAL-siderocalin in kidney disease. Biochim Biophys Acta 2012; 1823: 1451-1458.
35. Kuwabara T, Mori K, Mukoyama M, et al. Urinary neutrophil gelatinase-Associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 2009; 75: 285-294.
36. Fine L. The biology of renal hypertrophy. Kidney Int 1986; 29: 619-634.